2-201246297-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000264275.9(CASP8):c.-27+12185C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.877 in 152,188 control chromosomes in the GnomAD database, including 58,808 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.88 ( 58808 hom., cov: 30)
Consequence
CASP8
ENST00000264275.9 intron
ENST00000264275.9 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.44
Publications
5 publications found
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
- autoimmune lymphoproliferative syndrome type 2BInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.905 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASP8 | NM_001228.5 | c.-27+12185C>A | intron_variant | Intron 2 of 9 | NP_001219.2 | |||
CASP8 | NM_001400648.1 | c.-27+12185C>A | intron_variant | Intron 2 of 9 | NP_001387577.1 | |||
CASP8 | NM_001400651.1 | c.-27+12185C>A | intron_variant | Intron 2 of 9 | NP_001387580.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASP8 | ENST00000264275.9 | c.-27+12185C>A | intron_variant | Intron 2 of 9 | 1 | ENSP00000264275.5 | ||||
CASP8 | ENST00000392258.7 | c.-27+12185C>A | intron_variant | Intron 2 of 7 | 1 | ENSP00000376087.3 | ||||
CASP8 | ENST00000471383.5 | n.250+12185C>A | intron_variant | Intron 2 of 4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.877 AC: 133367AN: 152070Hom.: 58763 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
133367
AN:
152070
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.877 AC: 133467AN: 152188Hom.: 58808 Cov.: 30 AF XY: 0.874 AC XY: 65041AN XY: 74416 show subpopulations
GnomAD4 genome
AF:
AC:
133467
AN:
152188
Hom.:
Cov.:
30
AF XY:
AC XY:
65041
AN XY:
74416
show subpopulations
African (AFR)
AF:
AC:
34641
AN:
41478
American (AMR)
AF:
AC:
13224
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
3219
AN:
3472
East Asian (EAS)
AF:
AC:
3990
AN:
5164
South Asian (SAS)
AF:
AC:
3301
AN:
4826
European-Finnish (FIN)
AF:
AC:
10274
AN:
10614
Middle Eastern (MID)
AF:
AC:
231
AN:
294
European-Non Finnish (NFE)
AF:
AC:
61998
AN:
68030
Other (OTH)
AF:
AC:
1841
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
842
1684
2526
3368
4210
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2501
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.